Overview

Maraviroc in Rheumatoid Arthritis

Status:
Terminated

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate whether maraviroc, an investigational drug given with methotrexate (MTX) is safe and effective in the treatment of rheumatoid arthritis in adult patients.

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Maraviroc